200 related articles for article (PubMed ID: 36219058)
1. The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review.
Pham C; Sung C; Juhasz M; Yuan J; Senna M; Khera P; Mesinkovska N
J Drugs Dermatol; 2022 Oct; 21(10):1070-1083. PubMed ID: 36219058
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab Induced Hair Regrowth in Alopecia Totalis.
Bur D; Kim K; Rogge M
J Drugs Dermatol; 2023 Apr; 22(4):410-412. PubMed ID: 37026876
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.
Carnicle JM; Hendricks AJ; Shi VY
Dermatitis; 2021 Oct; 32(1S):e80-e82. PubMed ID: 31441782
[TBL] [Abstract][Full Text] [Related]
4. [Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].
Reinhold L; Lange K; Lindhof H; Homey B; Firouzi-Memarpuri P
Dermatologie (Heidelb); 2022 Jul; 73(7):556-559. PubMed ID: 34609537
[TBL] [Abstract][Full Text] [Related]
5. Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Guttman-Yassky E; Renert-Yuval Y; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Garcet S; Pavel AB; Lebwohl MG; Krueger JG
Allergy; 2022 Mar; 77(3):897-906. PubMed ID: 34460948
[TBL] [Abstract][Full Text] [Related]
6. Dupliumab therapy for alopecia areata: a case series and review of the literature.
Huang J; Jian J; Li T; Li M; Luo K; Deng S; Tang Y; Liu F; Zhao Z; Shi W; Li J
J Dermatolog Treat; 2024 Dec; 35(1):2312245. PubMed ID: 38342501
[TBL] [Abstract][Full Text] [Related]
7. Dupilumab for alopecia areata treatment: A double-edged sword?
Jin P; Wei L; Zhang Q; Gao T; Bai J; Dong L; Zhi L
J Cosmet Dermatol; 2022 Nov; 21(11):5546-5548. PubMed ID: 35652739
[TBL] [Abstract][Full Text] [Related]
8. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
[TBL] [Abstract][Full Text] [Related]
9. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
10. Long-Term Efficacy of Dupilumab in Alopecia Areata.
Kulkarni M; Rohan CA; Travers JB; Serrao R
Am J Case Rep; 2022 Jun; 23():e936488. PubMed ID: 35726185
[TBL] [Abstract][Full Text] [Related]
11. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
Fang H; Zhang F; Lin W; Jiang Y; Liu Q; Yang D
Front Immunol; 2024; 15():1395288. PubMed ID: 38903518
[TBL] [Abstract][Full Text] [Related]
12. Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.
Cai L; Wei Y; Zhao M; Zhuo J; Tao X; Lin M
Front Med (Lausanne); 2023; 10():1253795. PubMed ID: 37877023
[TBL] [Abstract][Full Text] [Related]
13. [Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].
Aszodi N; Pumnea T; Wollenberg A
Dtsch Med Wochenschr; 2019 May; 144(9):602-605. PubMed ID: 31026869
[TBL] [Abstract][Full Text] [Related]
14. Alopecia Areata Related Paradoxical Reactions in Patients on Dupilumab Therapy: A Systematic Review.
Sachdeva M; Witol A; Mufti A; Maliyar K; Yeung J
J Cutan Med Surg; 2021; 25(4):451-452. PubMed ID: 33586473
[No Abstract] [Full Text] [Related]
15. Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.
Romagnuolo M; Barbareschi M; Tavecchio S; Angileri L; Ferrucci SM
Skin Appendage Disord; 2022 Jan; 8(1):38-41. PubMed ID: 35118128
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab and alopecia: A Janus effect.
Patruno C; Napolitano M; Ferrillo M; Fabbrocini G
Dermatol Ther; 2019 Sep; 32(5):e13023. PubMed ID: 31306557
[TBL] [Abstract][Full Text] [Related]
17. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.
Kageyama R; Ito T; Hanai S; Morishita N; Nakazawa S; Fujiyama T; Honda T; Tokura Y
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807704
[TBL] [Abstract][Full Text] [Related]
18. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
Almutairi N; Nour TM; Hussain NH
Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
[TBL] [Abstract][Full Text] [Related]
19. Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
Renert-Yuval Y; Pavel AB; Del Duca E; Facheris P; Pagan AD; Bose S; Gómez-Arias PJ; Angelov M; Bares J; Chima M; Estrada YD; Garcet S; Lebwohl MG; Krueger JG; Guttman-Yassky E
Allergy; 2023 Apr; 78(4):1047-1059. PubMed ID: 36271804
[TBL] [Abstract][Full Text] [Related]
20. Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report.
Yan X; Tayier M; Cheang ST; Liao Z; Dong Y; Yang Y; Ye Y; Zhang X
Ther Adv Chronic Dis; 2023; 14():20406223231191049. PubMed ID: 37546700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
